Investigating Distinct Skin Microbial Communities and Skin Metabolome Profiles in Atopic Dermatitis

• Published in: International journal of molecular sciences 2024-05, Vol.25 (10), p.5211
• Main Authors: Kim, Suyeon, Cho, Minah, Jung, Eun Sung, Sim, Inseon, Woo, Yu Ri
• Format: Article
• Language: English
• Subjects: Adult; Advertising executives; Amino acids; Atopic dermatitis; Biotechnology industry; Case-Control Studies; Dermatitis; Dermatitis, Atopic - metabolism; Dermatitis, Atopic - microbiology; Development and progression; Fatty acids; Female; Humans; Investigations; Male; Metabolism; Metabolites; Metabolome; Metabolomics - methods; Microbiota; Middle Aged; RNA, Ribosomal, 16S - genetics; Skin; Skin - metabolism; Skin - microbiology; Skin diseases; Skin lesions; Young Adult
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25105211

Atopic dermatitis (AD) is a chronic inflammatory skin disorder influenced by genetic predisposition, environmental factors, immune dysregulation, and skin barrier dysfunction. The skin microbiome and metabolome play crucial roles in modulating the skin's immune environment and integrity. However, their specific contributions to AD remain unclear. We aimed to investigate the distinct skin microbial communities and skin metabolic compounds in AD patients compared to healthy controls (HCs). Seven patients with AD patients and seven HCs were enrolled, from whom skin samples were obtained for examination. The study involved 16S rRNA metagenomic sequencing and bioinformatics analysis as well as the use of gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) to detect metabolites associated with AD in the skin. We observed significant differences in microbial diversity between lesional and non-lesional skin of AD patients and HCs. overgrowth was prominent in AD lesions, while levels were decreased. Metabolomic analysis revealed elevated levels of several metabolites, including hypoxanthine and glycerol-3-phosphate in AD lesions, indicating perturbations in purine metabolism and energy production pathways. Moreover, we found a positive correlation between hypoxanthine and glycerol-3-phosphate and clinical severity of AD and overgrowth. These findings suggest potential biomarkers for monitoring AD severity. Further research is needed to elucidate the causal relationships between microbial dysbiosis, metabolic alterations, and AD progression, paving the way for targeted therapeutic interventions.